Journal of Shanghai Jiao Tong University (Medical Science) >

2024 , Vol. 44 >Issue 9: 1155 - 1161

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.09.010

Clinical research

Clinical and imaging analyses of primary mediastinal yolk sac tumor

  • Meili MA ,
  • Jiajun TENG ,
  • Zhiqiang GAO ,
  • Chunlei SHI ,
  • Hua ZHONG ,
  • Baohui HAN
Expand
  • Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
ZHONG Hua, E-mail: eddiedong8@hotmail.com.

Received date: 2024-05-09

  Accepted date: 2024-06-24

  Online published: 2024-09-28

Supported by

National Key Research and Development Program of China(2018YFC1314802);“Two-hundred Talents” Program of Shanghai Jiao Tong University School of Medicine(20161434)

Fold

Abstract

Objective ·To summarize the clinical features, imaging features, and diagnosis and treatment experience of primary mediastinal yolk sac tumor (YST). Methods ·Data of 29 patients with primary mediastinal YST, who attended Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine from September 2016 to May 2023, were collected and comprehensively analyzed, including imaging examination results, serum indicators, pathology reports and treatment methods. Results ·There were 22 cases of pure YST and 7 cases of mixed YST comprising 28 males and 1 female. The mean age of onset was (24.5±5.9) years. The initial symptoms were chest tightness (34.5%), chest pain (27.8%), cough (34.5%), expectoration (34.5%) and no specific symptoms (24.1%). Chest computerized tomography (CT) enhancement showed that all the 29 lesions were located in the anterior mediastinum. The maximum diameter of the lesions ranged from 5.6 cm to 18.2 cm. The lesions were irregular in shape, uneven in density, partially cystic and solid in density. The enhancement scan showed the solid part was slightly and moderately enhanced, and the low-density area was not enhanced. Tumor boundary was not clear because tumors often compressed and invaded surrounding tissues. Among the 29 newly diagnosed patients, serum alpha-fetoprotein (AFP) was significantly increased in 28 cases (1 case was not tested). Patients received multidisciplinary comprehensive treatment, including chemotherapy (25/29), surgery (26/29), and radiotherapy (8/29). Seven patients directly received surgery after diagnosis. Nineteen patients received chemotherapy first and then surgery; 16 (84.2%) cases were evaluated as lesion shrinkage after chemotherapy. After surgery, 73.1% (19/26) patients had a significant decrease in serum AFP. After chemotherapy, 56.0% (14/25) patients had decreased serum AFP. Conclusion ·Primary mediastinal YST usually occurs in middle-aged and young men, with certain clinical and radiographic features and elevated serum AFP, which requires multidisciplinary comprehensive treatment.

Key words： mediastinum; yolk sac tumor; computerized tomography; alpha fetoprotein; chemotherapy

Cite this article

Meili MA , Jiajun TENG , Zhiqiang GAO , Chunlei SHI , Hua ZHONG , Baohui HAN . Clinical and imaging analyses of primary mediastinal yolk sac tumor[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(9) : 1155 -1161 . DOI: 10.3969/j.issn.1674-8115.2024.09.010

References

1 LEVY D R, AGARAM N P, KAO C S, et al. Vasculogenic mesenchymal tumor: a clinicopathologic and molecular study of 55 cases of a distinctive neoplasm originating from mediastinal yolk sac tumor and an occasional precursor to angiosarcoma[J]. Am J Surg Pathol, 2021, 45(4): 463-476.
2 VAN LEEUWEN B J, BAVITZ M M, BOYLE S. Primary extragonadal yolk sac tumor originating from adrenal gland[J]. Can J Urol, 2019, 26(6): 10064-10066.
3 NERLI R B, AJAY G, SHIVANGOUDA P, et al. Prepubertal testicular tumors: our 10 years experience[J]. Indian J Cancer, 2010, 47(3): 292-295.
4 MCKENNEY J K, HEEREMA-MCKENNEY A, ROUSE R V. Extragonadal germ cell tumors: a review with emphasis on pathologic features, clinical prognostic variables, and differential diagnostic considerations[J]. Adv Anat Pathol, 2007, 14(2): 69-92.
5 BOKEMEYER C, NICHOLS C R, DROZ J P, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis[J]. J Clin Oncol, 2002, 20(7): 1864-1873.
6 MACCHIARINI P, OSTERTAG H. Uncommon primary mediastinal tumours[J]. Lancet Oncol, 2004, 5(2): 107-118.
7 马义祥, 刘敬伟, 齐康, 等. 原发性纵隔卵黄囊瘤7例[J]. 北京大学学报(医学版), 2019, 51(6): 1091-1095.
7 MA Y X, LIU J W, QI K, et al. Diagnosis and treatment of seven primary mediastinal yolk sac tumors[J]. Journal of Peking University (Health Sciences), 2019, 51(6): 1091-1095.
8 ZHU F, WANG L X, ZHAI X L. Primary mediastinal yolk sac tumor: a case report and literature review[J]. Int J Clin Exp Pathol, 2020, 13(11): 2772-2777.
9 LIU B, LIN G, LIU J W, et al. Primary mediastinal yolk sac tumor treated with platinum-based chemotherapy and extended resection: report of seven cases[J]. Thorac Cancer, 2018, 9(4): 491-494.
10 RODNEY A J, TANNIR N M, SIEFKER-RADTKE A O, et al. Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience[J]. Urol Oncol, 2012, 30(6): 879-885.
11 WEISSFERDT A, KALHOR N, RODRIGUEZ CANALES J, et al. Primary mediastinal yolk sac tumors: an immunohistochemical analysis of 14 cases[J]. Appl Immunohistochem Mol Morphol, 2019, 27(2): 125-133.
12 徐阳颺, 吴传勇, 娄加陶. 血清人绒毛膜促性腺激素β亚单位与甲胎蛋白对纵隔生殖细胞源性肿瘤的诊断价值[J]. 中华检验医学杂志, 2015, 38(10): 677-681.
12 XU Y Y, WU C Y, LOU J T. Clinical diagnostic value of serum β-hCG and AFP in mediastinal germ cell tumor[J]. Chinese Journal of Laboratory Medicine, 2015, 38(10): 677-681.
13 采丽, 章如松, 时姗姗, 等. 纵隔原发生殖细胞肿瘤56例临床病理分析[J]. 临床与实验病理学杂志, 2018, 34(2): 162-166.
13 CAI L, ZHANG R S, SHI S S, et al. Primary mediastinal germ cell tumors: the clinicopathologic analysis of 56 cases[J]. Chinese Journal of Clinical and Experimental Pathology, 2018, 34(2): 162-166.
14 谢紫东, 王成名, 卢绍路. 卵黄囊瘤的CT、MRI诊断与误诊分析[J]. 中国性科学, 2019, 28(7): 15-19.
14 XIE Z D, WANG C M, LU S L. CT and MRI diagnosis and misdiagnosis of yolk sac tumor[J]. Chinese Journal of Human Sexuality, 2019, 28(7): 15-19.
15 ZONG X, ZHANG Y, PENG X X, et al. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance[J]. Nat Commun, 2021, 12(1): 3579.
16 EL-ZAATARI Z M, RO J Y. Mediastinal germ cell tumors: a review and update on pathologic, clinical, and molecular features[J]. Adv Anat Pathol, 2021, 28(5): 335-350.
17 QIN L, ZHU M L, WANG T J, et al. The clinical features and prognostic outcomes of primary mediastinal yolk sac tumors: a retrospective analysis of 15 rare cases from multiple centers[J]. Medicine, 2021, 100(29): e26480.
18 GENG R X, ZHENG Z B, LIN Y X, et al. Clinical characteristics and prognostic factors of male yolk sac tumor: a Surveillance, Epidemiology, and End Results program study[J]. World J Urol, 2021, 39(4): 1211-1217.
19 FICHTNER A, RICHTER A, FILMAR S, et al. Primary mediastinal germ cell tumours: an immunohistochemical and molecular diagnostic approach[J]. Histopathology, 2022, 80(2): 381-396.
20 AROSHIDZE B, BOYAPATI L, POKHREL A, et al. Yolk sac tumor in the anterior mediastinum presenting as acute pericarditis[J]. Am J Case Rep, 2022, 23: e932616.
21 WU D Q, ZHANG K, ZHANG X Q. Primary mediastinal yolk sac tumor: a case report and literature review[J]. Clin Case Rep, 2023, 11(8): e7781.
22 DABSHA A, ELKHARBOTLY I A M H, YAGHMOUR M, et al. Survival difference among adult and pediatric mediastinal yolk sac tumors cases: a meta-analysis of case reports[J]. Eur J Surg Oncol, 2024, 50(3): 108019.
Options
Outlines

/

〈 〉